DEF: IN8bio Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing

IN8bio is asking stockholders to approve a reverse stock split to maintain its listing on the Nasdaq Capital Market and potentially improve stock marketability.

Summary

• IN8bio, Inc. is holding its 2025 Annual Meeting of Stockholders virtually on May 8, 2025.
• The meeting will address the election of three Class I directors, ratification of CohnReznick LLP as the independent accounting firm, and approval of a reverse stock split.
• The proposed reverse stock split would be at a ratio in the range of 1-for-15 to 1-for-30, determined by the board.
• The board believes a reverse stock split is necessary to maintain its Nasdaq Capital Market listing, which requires a minimum bid price of $1.00 per share.
• Failure to comply with Nasdaq's minimum bid price requirement by August 4, 2025, could result in delisting.
• The company is seeking authorization to implement the reverse stock split at any time before May 8, 2026.
• If a reverse stock split is implemented, stockholders may receive cash in lieu of fractional shares.
• The company's board of directors recommends voting for the election of directors, ratification of the accounting firm, and approval of the reverse stock split.

Sentiment

Score: 6

Explanation: The document is neutral in tone, primarily conveying information about the upcoming meeting and proposals. The need for a reverse stock split suggests underlying financial challenges, but the company is taking proactive steps to address them.

Positives

• Maintaining the Nasdaq listing could improve the marketability and liquidity of IN8bio's common stock.
• A reverse stock split could encourage interest and trading in the company's common stock.
• The company has hired Morrow Sodali LLC to solicit proxies.
• The company has established a Science and Technology Committee to assist with the Boards oversight of the strategic direction of our research and development activities.

Negatives

• A reverse stock split may decrease the liquidity of the common stock and result in higher transaction costs.
• The company cannot assure that the reverse stock split will increase the stock price for a sustained period.
• The effective increase in the authorized number of shares of our common stock as a result of the Reverse Stock Split could have anti-takeover implications.

Risks

• Failure to regain compliance with Nasdaq's minimum bid price requirement could result in delisting.
• The market price of the common stock may decrease due to factors unrelated to the reverse stock split.
• The proposed reverse stock split may decrease the liquidity of the common stock and result in higher transaction costs.
• The effective increase in the authorized number of shares of our common stock as a result of the Reverse Stock Split could have anti-takeover implications.

Future Outlook

The company is focused on maintaining its Nasdaq listing and improving the marketability and liquidity of its common stock.

Industry Context

Many companies with low stock prices consider reverse stock splits to improve their stock's appeal to institutional investors and maintain exchange listing compliance.

Comparison to Industry Standards

• Reverse stock splits are a common strategy for companies facing delisting from major exchanges, similar to actions taken by companies like Cytokinetics Incorporated (CYTK) and Geron Corporation (GERN) in the past.
• The specific ratio chosen (1-for-15 to 1-for-30) is within the typical range seen in reverse stock splits, comparable to what companies such as Ocugen Inc. (OCGN) have implemented.
• The potential for improved marketability and liquidity mirrors the goals of companies like Agenus Inc. (AGEN) when they underwent reverse stock splits.

Management Changes

Stakeholder Impact

• Shareholders will be impacted by the reverse stock split, potentially affecting the value and liquidity of their shares.
• Employees may be affected by the company's efforts to maintain its Nasdaq listing and improve its financial position.

Next Steps

• Stockholders need to vote on the proposals outlined in the proxy statement.
• The board of directors will decide whether to implement the reverse stock split and at what ratio.
• The company must regain compliance with Nasdaq's minimum bid price requirement by August 4, 2025.

Key Dates